Xilio Therapeutics, Inc.
XLO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$58,241 | -$76,404 | -$88,222 | -$75,800 |
| Dep. & Amort. | $1,644 | $1,900 | $1,847 | $1,499 |
| Deferred Tax | $0 | $0 | $0 | $222 |
| Stock-Based Comp. | $6,434 | $0 | $0 | $4,958 |
| Change in WC | $31,782 | -$1,658 | $2,004 | -$11,803 |
| Other Non-Cash | $3 | $7,542 | $8,648 | $173 |
| Operating Cash Flow | -$18,378 | -$68,620 | -$75,723 | -$80,751 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$36 | -$486 | -$1,867 | -$1,100 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$36 | -$486 | -$1,867 | -$1,100 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,382 | -$6,752 | -$85 | -$110 |
| Stock Issued | $6,825 | $202 | $16 | $116,359 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $25,753 | $0 | $0 | $144,419 |
| Financing Cash Flow | $29,196 | -$6,550 | -$69 | $260,668 |
| Forex Effect | $0 | -$25 | -$9 | $0 |
| Net Chg. in Cash | $10,782 | -$75,681 | -$77,668 | $178,817 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46,291 | $120,385 | $198,053 | $20,789 |
| End Cash | $57,073 | $44,704 | $120,385 | $199,606 |
| Free Cash Flow | -$18,414 | -$69,106 | -$77,590 | -$81,851 |